BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs LAS VEGAS, NV, Sept. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today new directions and activities intended to expand the Company’s role in...

BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets LAS VEGAS, NV, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the intention to spin off its Livestock Impact Division as a wholly-owned...

BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD LAS VEGAS, NV, April 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs,...

BioAdaptives, Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Internationally Acclaimed Health Scientist, Author and Patent Holder, Dr. Yaguang Liu LAS VEGAS, NV, April 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of Dr.Yaguang Liu to its Board of Directors. Edward Jacobs,...

BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management LY Research Patent # US 8,114,444 B2 is Valued at US$210,000,000 LAS VEGAS, NV, March 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the...